The state of the art of biomedical applications of optogenetics.
biomedical science
light sensitive proteins
optogenetics
optogenetics applications
photoreceptors
Journal
Lasers in surgery and medicine
ISSN: 1096-9101
Titre abrégé: Lasers Surg Med
Pays: United States
ID NLM: 8007168
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
revised:
08
07
2021
received:
07
12
2020
accepted:
23
07
2021
pubmed:
8
8
2021
medline:
9
3
2022
entrez:
7
8
2021
Statut:
ppublish
Résumé
Optogenetics has opened new insights into biomedical research with the ability to manipulate and control cellular activity using light in combination with genetically engineered photosensitive proteins. By stimulating with light, this method provides high spatiotemporal and high specificity resolution, which is in contrast to conventional pharmacological or electrical stimulation. Optogenetics was initially introduced to control neural activities but was gradually extended to other biomedical fields. In this paper, firstly, we summarize the current optogenetic tools stimulated by different light sources, including lasers, light-emitting diodes, and laser diodes. Second, we outline the variety of biomedical applications of optogenetics not only for neuronal circuits but also for various kinds of cells and tissues from cardiomyocytes to ganglion cells. Furthermore, we highlight the potential of this technique for treating neurological disorders, cardiac arrhythmia, visual impairment, hearing loss, and urinary bladder diseases as well as clarify the mechanisms underlying cancer progression and control of stem cell differentiation. We sought to summarize the various types of promising applications of optogenetics to treat a broad spectrum of disorders. It is conceivable to expect that optogenetics profits a growing number of patients suffering from a range of different diseases in the near future.
Sections du résumé
BACKGROUND AND OBJECTIVE
Optogenetics has opened new insights into biomedical research with the ability to manipulate and control cellular activity using light in combination with genetically engineered photosensitive proteins. By stimulating with light, this method provides high spatiotemporal and high specificity resolution, which is in contrast to conventional pharmacological or electrical stimulation. Optogenetics was initially introduced to control neural activities but was gradually extended to other biomedical fields.
STUDY DESIGN
In this paper, firstly, we summarize the current optogenetic tools stimulated by different light sources, including lasers, light-emitting diodes, and laser diodes. Second, we outline the variety of biomedical applications of optogenetics not only for neuronal circuits but also for various kinds of cells and tissues from cardiomyocytes to ganglion cells. Furthermore, we highlight the potential of this technique for treating neurological disorders, cardiac arrhythmia, visual impairment, hearing loss, and urinary bladder diseases as well as clarify the mechanisms underlying cancer progression and control of stem cell differentiation.
CONCLUSION
We sought to summarize the various types of promising applications of optogenetics to treat a broad spectrum of disorders. It is conceivable to expect that optogenetics profits a growing number of patients suffering from a range of different diseases in the near future.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
202-216Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Deisseroth K. Optogenetics. Nat Methods. 2011;8(1):26-9.
Pastrana E. Optogenetics: Controlling cell function with light. Nat Methods. 2011;8(1):24-5.
Zhang F, Vierock J, Yizhar O, Fenno LE, Tsunoda S, Kianianmomeni A, et al. The microbial opsin family of optogenetic tools. Cell. 2011;147:1446-57.
Mühlhäuser WW, Fischer A, Weber W, Radziwill G. Optogenetics-Bringing light into the darkness of mammalian signal transduction. Biochim Biophys Acta Mol Cell Res. 2017;1864(2):280-92.
Airan RD, Thompson KR, Fenno LE, Bernstein H, Deisseroth K. Temporally precise in vivo control of intracellular signalling. Nature. 2009;458(7241):1025-29.
Zhou Z, Tanaka KF, Matsunaga S, Iseki M, Watanabe M, Matsuki N, et al. Photoactivated adenylyl cyclase (PAC) reveals novel mechanisms underlying cAMP-dependent axonal morphogenesis. Sci Rep. 2016;6(1):1-12.
Vann KT, Xiong Z-G. Optogenetics for neurodegenerative diseases. Int J Physiol Pathophysiol Pharmacol. 2016;8(1):1-8.
Ordaz JD, Wu W, Xu X-M. Optogenetics and its application in neural degeneration and regeneration. Neural Regen Res. 2017;12(8):1197-1209.
Erofeev A, Zakharova O, Terekhin S, Plotnikova P, Bezprozvanny I, Vlasova O. Future of optogenetics: potential clinical applications? Opera Med Physiol. 2016;2(2):117-21.
Erofeev AI, Matveev MV, Terekhin SG, Zakharova OA, Plotnikova PV, Vlasova OL. The new method for studying neuronal activity: optogenetics. St. Petersburg Polytechnical Univ J Phys Math. 2015;1(3):256-63.
Numan M. Neurobiology of social behavior: toward an understanding of the prosocial and antisocial brain. Academic Press; 2014.
Krames E, Peckham PH, Rezai AR. Neuromodulation: comprehensive textbook of principles, technologies, and therapies. Academic Press; 2018.
Schroll C, Riemensperger T, Bucher D, Ehmer J, Völler T, Erbguth K, et al. Light-induced activation of distinct modulatory neurons triggers appetitive or aversive learning in Drosophila larvae. Curr Biol. 2006;16(17):1741-47.
Adamantidis AR, Zhang F, Aravanis AM, Deisseroth K, de Lecea L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature. 2007;450(7168):420-424.
Arenkiel BR, Peca J, Davison IG, Feliciano C, Deisseroth K, Augustine GJ, et al. In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2. Neuron. 2007;54(2):205-18.
Zhao S, Cunha C, Zhang F, Liu Q, Gloss B, Deisseroth K, et al. Improved expression of halorhodopsin for light-induced silencing of neuronal activity. Brain Cell Biol. 2008;36(1):141-54.
Zhang F, Wang LP, Brauner M, Liewald JF, Kay K, Watzke N, et al. Multimodal fast optical interrogation of neural circuitry. Nature. 2007;446(7136):633-639.
Gradinaru V, Thompson KR, Deisseroth K. eNpHR: a Natronomonas halorhodopsin enhanced for optogenetic applications. Brain Cell Biol. 2008;36(1-4):129-39.
Busskamp V, Duebel J, Balya D, Fradot M, Viney TJ, Siegert S, et al. Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science. 2010;329(5990):413-417.
Gradinaru V, Zhang F, Ramakrishnan C, Mattis J, Prakash R, Diester I, et al. Molecular and cellular approaches for diversifying and extending optogenetics. Cell. 2010;141(1):154-65.
Mohanty SK, Lakshminarayananan V. Optical techniques in optogenetics. J Mod Opt. 2015;62(12):949-70.
Adamantidis AR, Zhang F, Aravanis AM, Deisseroth K, de Lecea L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature. 2007;450(7168):420-4.
Farah N, Reutsky I, Shoham S. Patterned optical activation of retinal ganglion cells. In 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2007. IEEE.
Witten IB, Lin SC, Brodsky M, Prakash R, Diester I, Anikeeva P, et al. Cholinergic interneurons control local circuit activity and cocaine conditioning. Science. 2010;330(6011):1677-81.
Chen CH, Fremont R, Arteaga-Bracho EE, Khodakhah K. Short latency cerebellar modulation of the basal ganglia. Nature Neurosci. 2014;17(12):1767-75.
Proville RD, Spolidoro M, Guyon N, Dugué GP, Selimi F, Isope P, et al. Cerebellum involvement in cortical sensorimotor circuits for the control of voluntary movements. Nat Neurosci. 2014;17(9):1233-9.
Simpson LA, Eng JJ, Hsieh JT, Wolfe DL, Spinal Cord Injury Rehabilitation Evidence Scire Research Team. The health and life priorities of individuals with spinal cord injury: a systematic review. J Neurotrauma. 2012;29(8):1548-55.
Jayaprakash N, Wang Z, Hoeynck B, Krueger N, Kramer A, Balle E, et al. Optogenetic interrogation of functional synapse formation by corticospinal tract axons in the injured spinal cord. J Neurosci. 2016;36(21):5877-90.
Rahman MH, Nam Y, Kim JH, Lee WH, Suk K. Optogenetics of the spinal cord: use of channelrhodopsin proteins for interrogation of spinal cord circuits. Curr Protein Pept Sci. 2018;19(7):714-24.
Towne C, Montgomery KL, Iyer SM, Deisseroth K, Delp SL. Optogenetic control of targeted peripheral axons in freely moving animals. PLOS One. 2013;8(8):e72691.
Yohn DC, Miles GB, Rafuse VF, Brownstone RM. Transplanted mouse embryonic stem-cell-derived motoneurons form functional motor units and reduce muscle atrophy. J Neurosci. 2008;28(47):12409-18.
Choudhury GR, Ding S. Reactive astrocytes and therapeutic potential in focal ischemic stroke. Neurobiol Dis. 2016;85:234-44.
Cheng MY, Wang EH, Woodson WJ, Wang S, Sun G, Lee AG, et al. Optogenetic neuronal stimulation promotes functional recovery after stroke. Proc Natl Acad Sci. 2014;111(35):12913-8.
Daadi MM, Klausner JQ, Bajar B, Goshen I, Lee-Messer C, Lee SY, et al. Optogenetic stimulation of neural grafts enhances neurotransmission and downregulates the inflammatory response in experimental stroke model. Cell Transplant. 2016;25(7):1371-80.
Ono K, Suzuki H, Yamamoto R, Sahashi H, Takido Y, Sawada M. Optogenetic control of cell differentiation in channelrhodopsin-2-expressing OS3, a bipotential glial progenitor cell line. Neurochem Int. 2017;104:49-63.
Hughes RM, Freeman DJ, Lamb KN, Pollet RM, Smith WJ, Lawrence DS. Optogenetic apoptosis: light-triggered cell death. Angew Chem Int Ed. 2015;54(41):12064-68.
Shao J, Wang M, Yu G, Zhu S, Yu Y, Heng BC, et al. Synthetic far-red light-mediated CRISPR-dCas9 device for inducing functional neuronal differentiation. Proc Natl Acad Sci USA. 2018;115(29):E6722-30.
Paschon V, Correia FF, Morena BC, da Silva VA, dos Santos GB, da Silva MCC, et al. CRISPR, prime editing, optogenetics, and DREADDs: new therapeutic approaches provided by emerging technologies in the treatment of spinal cord injury. Mol Neurobiol. 2020;57:1-16.
Petersen ED, Sharkey ED, Pal A, Shafau LO, Zenchak JR, Peña AJ, et al. Restoring function after severe spinal cord injury through bioluminescence-driven optogenetics bioRxiv, 2019:710194.
Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron. 2006;52(1):61-76.
Goldenberg MM. Multiple sclerosis review. Pharmacy and Therapeutics. 2012;37(3):175-84.
Li Q, Brus-Ramer M, Martin JH, McDonald JW. Electrical stimulation of the medullary pyramid promotes proliferation and differentiation of oligodendrocyte progenitor cells in the corticospinal tract of the adult rat. Neurosci Lett. 2010;479(2):128-33.
Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, Wood LS, et al. Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science. 2014;344(6183):1252304.
Jung K, Park JH, Kim SY, Jeon NL, Cho SR, Hyung S. Optogenetic stimulation promotes Schwann cell proliferation, differentiation, and myelination in vitro. Sci Rep. 2019;9(1):3487.
Tønnesen J. Optogenetic cell control in experimental models of neurological disorders. Behav Brain Res. 2013;255:35-43.
Goshen I. The optogenetic revolution in memory research. Trends Neurosci. 2014;37(9):511-22.
Jazayeri M, Remington E. Optogenetics advances in primate visual pathway. Neuron. 2016;90(1):8-10.
Stamp LA, Gwynne RM, Foong J, Lomax AE, Hao MM, Kaplan DI, et al. Optogenetic demonstration of functional innervation of mouse colon by neurons derived from transplanted neural cells. Gastroenterology. 2017;152(6):1407-18.
El Koussy MM, Jadavji NM. Therapeutic potential of optogenetic treatment for individuals with multiple sclerosis. J Young Investig. 2017;33:4.
Kumar A, Singh A. A review on Alzheimer's disease pathophysiology and its management: an update. Pharmacol Rep. 2015;67(2):195-203.
Yamamoto K, Tanei ZI, Hashimoto T, Wakabayashi T, Okuno H, Naka Y, et al. Chronic optogenetic activation augments Aβ pathology in a mouse model of Alzheimer disease. Cell Rep. 2015;11(6):859-65.
Roy DS, Arons A, Mitchell TI, Pignatelli M, Ryan TJ, Tonegawa S. Memory retrieval by activating engram cells in mouse models of early Alzheimer's disease. Nature. 2016;531(7595):508-12.
Iaccarino HF, Singer AC, Martorell AJ, Rudenko A, Gao F, Gillingham TZ, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016;540(7632):230-235.
Kastanenka KV, Hou SS, Shakerdge N, Logan R, Feng D, Wegmann S, et al. Optogenetic restoration of disrupted slow oscillations halts amyloid deposition and restores calcium homeostasis in an animal model of Alzheimer's disease. PLOS One. 2017;12(1):e0170275.
Kastanenka KV, Calvo-Rodriguez M, Hou SS, Zhou H, Takeda S, Arbel-Ornath M, et al. Frequency-dependent exacerbation of Alzheimer's disease neuropathophysiology. Sci Rep. 2019;9(1):8964.
Raza C, Anjum R. Parkinson's disease: mechanisms, translational models and management strategies. Life Sci. 2019;226:77-90.
Benabid AL. Deep brain stimulation for Parkinson's disease. Curr Opin Neurobiol. 2003;13(6):696-706.
Steinbeck JA, Choi SJ, Mrejeru A, Ganat Y, Deisseroth K, Sulzer D, et al. Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model. Nature Biotechnol. 2015;33(2):204-9.
Qi C, Varga S, Oh SJ, Lee CJ, Lee D. Optogenetic rescue of locomotor dysfunction and dopaminergic degeneration caused by alpha-synuclein and eko genes. Exp Neurobiol. 2017;26(2):97-103.
Sanders TH, Jaeger D. Optogenetic stimulation of cortico-subthalamic projections is sufficient to ameliorate bradykinesia in 6-ohda lesioned mice. Neurobiol Dis. 2016;95:225-37.
Magno LAV, Tenza-Ferrer H, Collodetti M, Aguiar M, Rodrigues A, da Silva RS, et al. Optogenetic stimulation of the M2 cortex reverts motor dysfunction in a mouse model of Parkinson's Disease. J Neurosci. 2019;39(17):3234-48.
Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-82.
Yang C-Y, Dao RL, Lee TJ, Lu CW, Yang CH, Hung SI, et al. Severe cutaneous adverse reactions to antiepileptic drugs in Asians. Neurology. 2011;77(23):2025-33.
Morrell MJ, Halpern C. Responsive direct brain stimulation for epilepsy. Neurosurg Clin. 2016;27(1):111-21.
Camporeze B, Manica BA, Bonafé GA, Ferreira J, Diniz AL, de Oliveira C, et al. Optogenetics: the new molecular approach to control functions of neural cells in epilepsy, depression and tumors of the central nervous system. Am J Cancer Res. 2018;8:1900-18.
Tønnesen J, Sørensen AT, Deisseroth K, Lundberg C, Kokaia M. Optogenetic control of epileptiform activity. Proc Natl Acad Sci USA. 2009;106(29):12162-7.
Wykes RC, Heeroma JH, Mantoan L, Zheng K, MacDonald DC, Deisseroth K, et al. Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Sci Transl Med. 2012;4(161):161ra152.
Krook-Magnuson E, Szabo GG, Armstrong C, Oijala M, Soltesz I. Cerebellar directed optogenetic intervention inhibits spontaneous hippocampal seizures in a mouse model of temporal lobe epilepsy. eNeuro. 2014;1:1.
Soper C, Wicker E, Kulick CV, N'Gouemo P, Forcelli PA. Optogenetic activation of superior colliculus neurons suppresses seizures originating in diverse brain networks. Neurobiol Dis. 2016;87:102-15.
Cela E, McFarlan AR, Chung AJ, Wang T, Chierzi S, Murai KK, et al. An optogenetic kindling model of neocortical epilepsy. Sci Rep. 2019;9(1):1-12.
Cela E, Sjöström PJ. Novel optogenetic approaches in epilepsy research. Front Neurosci. 2019;13:947.
Cela E, Sjöström PJ. A step-by-step protocol for optogenetic kindling. Front Neural Circuits. 2020;14:3.
Johnson AC, Louwies T, Ligon CO, Greenwood-Van Meerveld B. Enlightening the frontiers of neurogastroenterology through optogenetics. Am J Physiol Gastrointest Liver Physiol. 2020;319(3):G391-99.
Perez-Medina AL, Galligan JJ. Optogenetic analysis of neuromuscular transmission in the colon of ChAT-ChR2-YFP BAC transgenic mice. Am J Physiol Gastrointest Liver Physiol. 2019;317(5):G569-79.
Hibberd TJ, Feng J, Luo J, Yang P, Samineni VK, Gereau RW, et al. Optogenetic induction of colonic motility in mice. Gastroenterology. 2018;155(2):514-28.
Gould TW, Swope WA, Heredia DJ, Corrigan RD, Smith TK. Activity within specific enteric neurochemical subtypes is correlated with distinct patterns of gastrointestinal motility in the murine colon. Am J Physiol Gastrointest Liver Physiol. 2019;317(2):G210-21.
Fujii K, Nakajo K, Egashira Y, Yamamoto Y, Kitada K, Taniguchi K, et al. Gastrointestinal neurons expressing HCN4 regulate retrograde peristalsis. Cell Rep. 2020;30(9):2879-88.
Zhu Y, Feng B, Schwartz ES, Gebhart GF, Prescott SA. Novel method to assess axonal excitability using channelrhodopsin-based photoactivation. J Neurophysiol. 2015;113(7):2242-49.
Makadia PA, Najjar SA, Saloman JL, Adelman P, Feng B, Margiotta JF, et al. Optogenetic activation of colon epithelium of the mouse produces high-frequency bursting in extrinsic colon afferents and engages visceromotor responses. J Neurosci. 2018;38(25):5788-98.
Johnson AC, Latorre R, Ligon CO, Greenwood-Van Meerveld B. Visceral hypersensitivity induced by optogenetic activation of the amygdala in conscious rats. Am J Physiol Gastrointest Liver Physiol. 2018;314(3):G448-57.
Bruegmann T, Malan D, Hesse M, Beiert T, Fuegemann CJ, Fleischmann BK, et al. Optogenetic control of heart muscle in vitro and in vivo. Nat Methods. 2010;7(11):897-900.
Arrenberg AB, Stainier DY, Baier H, Huisken J. Optogenetic control of cardiac function. Science. 2010;330(6006):971-974.
Lin JY, Knutsen PM, Muller A, Kleinfeld D, Tsien RY. ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat Neurosci. 2013;16(10):1499-508.
Berndt A, Schoenenberger P, Mattis J, Tye KM, Deisseroth K, Hegemann P, et al. High-efficiency channelrhodopsins for fast neuronal stimulation at low light levels. Proc Natl Acad Sci USA. 2011;108(18):7595-600.
Kleinlogel S, Feldbauer K, Dempski RE, Fotis H, Wood PG, Bamann C, et al. Ultra light-sensitive and fast neuronal activation with the Ca2+-permeable channelrhodopsin CatCh. Nat Neurosci. 2011;14(4):513-518.
Yu J, Chen K, Lucero RV, Ambrosi CM, Entcheva E. Cardiac optogenetics: enhancement by all-trans-retinal. Sci Rep. 2015;5:16542.
Keshmiri Neghab H, Goliaei B, Saboury AA, Esmaeeli Djavid G, Pornour M, Hong J, et al. Modulation of cardiac optogenetics by vitamin A. Biofactors. 2019;45(6):983-90.
Jia Z, Valiunas V, Lu Z, Bien H, Liu H, Wang HZ, et al. Stimulating cardiac muscle by light: cardiac optogenetics by cell delivery. Circ Arrhythm Electrophysiol. 2011;4(5):753-60.
Berndt A, Lee SY, Ramakrishnan C, Deisseroth K. Structure-guided transformation of channelrhodopsin into a light-activated chloride channel. Science. 2014;344(6182):420-424.
Makowka P, Bruegmann T, Dusend V, Malan D, Beiert T, Hesse M, et al. Optogenetic stimulation of G s-signaling in the heart with high spatio-temporal precision. Nat Commun. 2019;10(1):1281.
Knollmann BC. Pacing lightly: optogenetics gets to the heart. Nat Methods. 2010;7(11):889-91.
Bruegmann T, Boyle PM, Vogt CC, Karathanos TV, Arevalo HJ, Fleischmann BK, et al. Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations. J Clin Invest. 2016;126(10):3894-3904.
Gordan R, Gwathmey JK, Xie L-H. Autonomic and endocrine control of cardiovascular function. World J Cardiol. 2015;7(4):204-14.
Wang X, Piñol RA, Byrne P, Mendelowitz D. Optogenetic stimulation of locus ceruleus neurons augments inhibitory transmission to parasympathetic cardiac vagal neurons via activation of brainstem α1 and β1 receptors. J Neurosci. 2014;34(18):6182-89.
Wengrowski AM, Wang X, Tapa S, Posnack NG, Mendelowitz D, Kay MW. Optogenetic release of norepinephrine from cardiac sympathetic neurons alters mechanical and electrical function. Cardiovasc Res. 2014;105(2):143-50.
Repina NA, Rosenbloom A, Mukherjee A, Schaffer DV, Kane RS. At light speed: advances in optogenetic systems for regulating cell signaling and behavior. Annu Rev Chem Biomol Eng. 2017;8:13-39.
Inglés-Prieto Á, Reichhart E, Muellner MK, Nowak M, Nijman SM, Grusch M, et al. Light-assisted small-molecule screening against protein kinases. Nat Chem Biol. 2015;11(12):952-4.
Kiełbus M, Czapiński J, Odrzywolski A, Stasiak G, Szymańska K, Kałafut J, et al. Optogenetics in cancer drug discovery. Exp Opin Drug Discov. 2018;13(5):459-72.
Yang F, Tu J, Pan JQ, Luo HL, Liu YH, Wan J, et al. Light-controlled inhibition of malignant glioma by opsin gene transfer. Cell Death Dis. 2013;4(10):e893-93.
Tichy A-M, Gerrard EJ, Sexton PM, Janovjak H. Light-activated chimeric GPCRs: limitations and opportunities. Curr Opin Struct Biol. 2019;57:196-203.
Xu Y, Hyun Y-M, Lim K, Lee H, Cummings RJ, Gerber SA, et al. Optogenetic control of chemokine receptor signal and T-cell migration. Proc Natl Acad Sci USA. 2014;111(17):6371-76.
Grusch M, Schelch K, Riedler R, Reichhart E, Differ C, Berger W, et al. Spatio-temporally precise activation of engineered receptor tyrosine kinases by light. EMBO J. 2014;33(15):1713-26.
Kim N, Kim JM, Lee M, Kim CY, Chang KY, Heo WD. Spatiotemporal control of fibroblast growth factor receptor signals by blue light. Chem Biol. 2014;21(7):903-12.
Li Y, Lee M, Kim N, Wu G, Deng D, Kim JM, et al. Spatiotemporal control of TGF-β signaling with light. ACS Synth Biol. 2018;7(2):443-51.
Zhou X, Wang J, Chen J, Qi Y, Di N, Jin L, et al. Optogenetic control of epithelial-mesenchymal transition in cancer cells. Sci Rep. 2018;8(1):14098.
Chatelle CV, Hövermann D, Müller A, Wagner HJ, Weber W, Radziwill G. Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors. Sci Rep. 2016;6:23713.
Toettcher JE, Weiner OD, Lim WA. Using optogenetics to interrogate the dynamic control of signal transmission by the Ras/Erk module. Cell. 2013;155(6):1422-34.
Mills E, Chen X, Pham E, Wong S, Truong K. Engineering a photoactivated caspase-7 for rapid induction of apoptosis. ACS Synth Biol. 2011;1(3):75-82.
Nihongaki Y, Suzuki H, Kawano F, Sato M. Genetically engineered photoinducible homodimerization system with improved dimer-forming efficiency. ACS Chem Biol. 2014;9(3):617-21.
Zhou XX, Chung HK, Lam AJ, Lin MZ. Optical control of protein activity by fluorescent protein domains. Science. 2012;338(6108):810-814.
Yi JJ, Wang H, Vilela M, Danuser G, Hahn KM. Manipulation of endogenous kinase activity in living cells using photoswitchable inhibitory peptides. ACS Synth Biol. 2014;3(11):788-95.
Lee S, Park H, Kyung T, Kim NY, Kim S, Kim J, et al. Reversible protein inactivation by optogenetic trapping in cells. Nat Methods. 2014;11(6):633-6.
Taslimi A, Vrana JD, Chen D, Borinskaya S, Mayer BJ, Kennedy MJ, et al. An optimized optogenetic clustering tool for probing protein interaction and function. Nat Commun. 2014;5:4925.
Duan L, Che D, Zhang K, Ong Q, Guo S, Cui B. Optogenetic control of molecular motors and organelle distributions in cells. Chem Biol. 2015;22(5):671-82.
Van Bergeijk P, Adrian M, Hoogenraad CC, Kapitein LC. Optogenetic control of organelle transport and positioning. Nature. 2015;518(7537):111-114.
Niopek D, Benzinger D, Roensch J, Draebing T, Wehler P, Eils R, et al. Engineering light-inducible nuclear localization signals for precise spatiotemporal control of protein dynamics in living cells. Nat Commun. 2014;5:4404.
Crefcoeur RP, Yin R, Ulm R, Halazonetis TD. Ultraviolet-B-mediated induction of protein-protein interactions in mammalian cells. Nat Commun. 2013;4:1779.
Beyer HM, Juillot S, Herbst K, Samodelov SL, Müller K, Schamel WW, et al. Red light-regulated reversible nuclear localization of proteins in mammalian cells and zebrafish. ACS Synth Biol. 2015;4(9):951-958.
Niopek D, Wehler P, Roensch J, Eils R, Di Ventura B. Optogenetic control of nuclear protein export. Nat Commun. 2016;7:10624.
SWITCH C. Formation of arabidopsis cryptochrome 2 photobodies in mammalian nuclei. J Biol Chem. 2013;288(32):23244-51.
Motta-Mena LB, Reade A, Mallory MJ, Glantz S, Weiner OD, Lynch KW, et al. An optogenetic gene expression system with rapid activation and deactivation kinetics. Nat Chem Biol. 2014;10(3):196-202.
Zhao B, Wang Y, Tan X, Zheng X, Wang F, Ke K, et al. An optogenetic controllable T cell system for hepatocellular carcinoma immunotherapy. Theranostics. 2019;9(7):1837-50.
Weick JP, Johnson MA, Skroch SP, Williams JC, Deisseroth K, Zhang SC. Functional control of transplantable human ESC-derived neurons via optogenetic targeting. Stem Cells. 2010;28(11):2008-16.
Weick JP, Liu Y, Zhang S-C. Human embryonic stem cell-derived neurons adopt and regulate the activity of an established neural network. Proc Natl Acad Sci USA. 2011;108(50):20189-94.
Singh VK, Kalsan M, Kumar N, Saini A, Chandra R. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol. 2015;3:2.
Byers B, Lee HJ, Liu J, Weitz AJ, Lin P, Zhang P, et al. Direct in vivo assessment of human stem cell graft-host neural circuits. Neuroimage. 2015;114:328-37.
Reinbothe TM, Safi F, Axelsson AS, Mollet IG, Rosengren AH. Optogenetic control of insulin secretion in intact pancreatic islets with β-cell-specific expression of Channelrhodopsin-2. Islets. 2014;6(1):e28095.
Kushibiki T, Okawa S, Hirasawa T, Ishihara M. Optogenetic control of insulin secretion by pancreatic β-cells in vitro and in vivo. Gene Therapy. 2015;22(7):553-9.
Zhang F, Tzanakakis ES. Optogenetic regulation of insulin secretion in pancreatic β-cells. Sci Rep. 2017;7(1):9357.
Zhang F, Tzanakakis ES. Amelioration of diabetes in a murine model upon transplantation of pancreatic β-cells with optogenetic control of cyclic adenosine monophosphate. ACS Synth Biol. 2019;8(10):2248-55.
Baker CK, Flannery JG. Innovative optogenetic strategies for vision restoration. Front Cell Neurosci. 2018;12:12.
Bi A, Cui J, Ma YP, Olshevskaya E, Pu M, Dizhoor AM, et al. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron. 2006;50(1):23-33.
Zhang F, Prigge M, Beyrière F, Tsunoda SP, Mattis J, Yizhar O, et al. Red-shifted optogenetic excitation: a tool for fast neural control derived from Volvox carteri. Nature Neurosci. 2008;11(6):631-3.
Lin JY, Knutsen PM, Muller A, Kleinfeld D, Tsien RY. ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat Neurosci. 2013;16(10):1499-508.
Tomita H, Sugano E, Murayama N, Ozaki T, Nishiyama F, Tabata K, et al. Restoration of the majority of the visual spectrum by using modified Volvox channelrhodopsin-1. Mol Ther. 2014;22(8):1434-40.
Sengupta A, Chaffiol A, Macé E, Caplette R, Desrosiers M, Lampič M, et al. Red-shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina. EMBO Mol Med. 2016;8(11):1248-64.
Lin B, Koizumi A, Tanaka N, Panda S, Masland RH. Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin. Proc Natl Acad Sci USA. 2008;105(41):16009-14.
Cehajic-Kapetanovic J, Eleftheriou C, Allen AE, Milosavljevic N, Pienaar A, Bedford R, et al. Restoration of vision with ectopic expression of human rod opsin. Curr Biol. 2015;25(16):2111-22.
Gaub BM, Berry MH, Holt AE, Isacoff EY, Flannery JG. Optogenetic vision restoration using rhodopsin for enhanced sensitivity. Mol Ther. 2015;23(10):1562-71.
Moser T, Dieter A. Towards optogenetic approaches for hearing restoration. Biochem Biophys Res Commun. 2020;527:337-42.
Berenstein CK, Mens LH, Mulder JJ, Vanpoucke FJ. Current steering and current focusing in cochlear implants: comparison of monopolar, tripolar, and virtual channel electrode configurations. Ear Hear. 2008;29(2):250-60.
Hernandez VH, Gehrt A, Reuter K, Jing Z, Jeschke M, Mendoza Schulz A, et al. Optogenetic stimulation of the auditory pathway. J Clin Invest. 2014;124(3):1114-29.
Mager T, Lopez de la Morena D, Senn V, Schlotte J, D Errico A, Feldbauer K, et al. High frequency neural spiking and auditory signaling by ultrafast red-shifted optogenetics. Nat Commun. 2018;9(1):1-14.
Klapoetke NC, Murata Y, Kim SS, Pulver SR, Birdsey-Benson A, Cho YK, et al. Independent optical excitation of distinct neural populations. Nat Methods. 2014;11(3):338-46.
Park E, Lee K-S. A new approach to urinary bladder control with optogenetics. Investig Clin Urol. 2019;60(2):61-3.
Park JH, Hong JK, Jang JY, An J, Lee KS, Kang TM, et al. Optogenetic modulation of urinary bladder contraction for lower urinary tract dysfunction. Sci Rep. 2017;7(1):1-13.
Samineni VK, Mickle AD, Yoon J, Grajales-Reyes JG, Pullen MY, Crawford KE, et al. Optogenetic silencing of nociceptive primary afferents reduces evoked and ongoing bladder pain. Sci Rep. 2017;7(1):15865.
Mickle AD, Won SM, Noh KN, Yoon J, Meacham KW, Xue Y, et al. A wireless closed-loop system for optogenetic peripheral neuromodulation. Nature. 2019;565(7739):361-365.
Chen S, Weitemier AZ, Zeng X, He L, Wang X, Tao Y, et al. Near-infrared deep brain stimulation via upconversion nanoparticle-mediated optogenetics. Science. 2018;359(6376):679-84.
Klapoetke NC, Murata Y, Kim SS, Pulver SR, Birdsey-Benson A, Cho YK, et al. Independent optical excitation of distinct neural populations. Nat Methods. 2014;11(3):338-46.
Boyle PM, Karathanos TV, Trayanova NA. “Beauty is a light in the heart”: the transformative potential of optogenetics for clinical applications in cardiovascular medicine. Trends Cardiovascul Med. 2015;25(2):73-81.
Kim T-i, McCall JG, Jung YH, Huang X, Siuda ER, Li Y, et al. Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science. 2013;340(6129):211-216.
Liu J. Syringe injectable electronics. In: Biomimetics through nanoelectronics. Springer; 2018. p. 65-93.